These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cardiovascular disease. Risérus U World Rev Nutr Diet; 2015; 111():94-9. PubMed ID: 25418396 [No Abstract] [Full Text] [Related]
5. Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study. Bartlett J; Predazzi IM; Williams SM; Bush WS; Kim Y; Havas S; Toth PP; Fazio S; Miller M Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):206-212. PubMed ID: 27166203 [TBL] [Abstract][Full Text] [Related]
7. Impact of Lipid-Lowering Therapy on Mortality According to the Baseline Non-HDL Cholesterol Level: A Meta-Analysis. Masson W; Lobo M; Siniawski D; Molinero G; Huerín M; Nogueira JP High Blood Press Cardiovasc Prev; 2019 Aug; 26(4):263-272. PubMed ID: 31313082 [TBL] [Abstract][Full Text] [Related]
8. Obesity, ultrasound indexes of fat depots and lipid goal attainment in patients with high and very high cardiovascular risk: A novel approach towards better risk reduction. Haberka M; Okopień B; Gąsior Z Nutr Metab Cardiovasc Dis; 2016 Feb; 26(2):123-33. PubMed ID: 26830392 [TBL] [Abstract][Full Text] [Related]
9. Roles of Achieved Levels of Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein on Cardiovascular Outcome in Statin Therapy. Hyun MH; Lee Y; Choi BG; Na JO; Choi CU; Kim JW; Kim EJ; Rha SW; Park CG; Lee E; Seo HS Cardiovasc Ther; 2019; 2019():3824823. PubMed ID: 31885691 [TBL] [Abstract][Full Text] [Related]
10. Inflammatory status and uricaemia determine HDL-cholesterol levels in hypertensive adults over 65: an analysis of the FAPRES register. Quintanilla MA; Andrés M; Pascual E; Pallarés V; Fácila L; Morillas P; Rheumatol Int; 2017 Jun; 37(6):941-948. PubMed ID: 28293775 [TBL] [Abstract][Full Text] [Related]
11. The systematic coronary risk evaluation (SCORE) for the prevention of cardiovascular diseases. Does evidence exist for its effectiveness? A systematic review. Tomasik T; Krzysztoń J; Dubas-Jakóbczyk K; Kijowska V; Windak A Acta Cardiol; 2017 Aug; 72(4):370-379. PubMed ID: 28705107 [TBL] [Abstract][Full Text] [Related]
12. CETP-Inhibition and HDL-Cholesterol: A Story of CV Risk or CV Benefit, or Both. Nicholls SJ Clin Pharmacol Ther; 2018 Aug; 104(2):297-300. PubMed ID: 29901215 [TBL] [Abstract][Full Text] [Related]
13. Dyslipidemia therapy update: the importance of full lipid profile assessment. Menown IB; Murtagh G; Maher V; Cooney MT; Graham IM; Tomkin G Adv Ther; 2009 Jul; 26(7):711-8. PubMed ID: 19649582 [TBL] [Abstract][Full Text] [Related]
15. Proposed guidelines for hypertriglyceridemia in Japan with non-HDL cholesterol as the second target. Shimano H; Arai H; Harada-Shiba M; Ueshima H; Ohta T; Yamashita S; Gotoda T; Kiyohara Y; Hayashi T; Kobayashi J; Shimamoto K; Bujo H; Ishibashi S; Shirai K; Oikawa S; Saito Y; Yamada N J Atheroscler Thromb; 2008 Jun; 15(3):116-21. PubMed ID: 18603817 [TBL] [Abstract][Full Text] [Related]
16. HDL and Reverse Cholesterol Transport Biomarkers. Riggs KA; Rohatgi A Methodist Debakey Cardiovasc J; 2019; 15(1):39-46. PubMed ID: 31049148 [TBL] [Abstract][Full Text] [Related]
17. Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients. Yadav R; Liu Y; Kwok S; Hama S; France M; Eatough R; Pemberton P; Schofield J; Siahmansur TJ; Malik R; Ammori BA; Issa B; Younis N; Donn R; Stevens A; Durrington P; Soran H J Am Heart Assoc; 2015 Sep; 4(9):e001508. PubMed ID: 26374297 [TBL] [Abstract][Full Text] [Related]
18. Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice. Arca M; Ansell D; Averna M; Fanelli F; Gorcyca K; Iorga ŞR; Maggioni AP; Paizis G; Tomic R; Catapano AL Atherosclerosis; 2018 Apr; 271():120-127. PubMed ID: 29499359 [TBL] [Abstract][Full Text] [Related]
19. Frequency of Attainment of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol Goals in Cardiovascular Clinical Practice (from the National Cardiovascular Data Registry PINNACLE Registry). Spinler SA; Cziraky MJ; Willey VJ; Tang F; Maddox TM; Thomas T; Dueñas GG; Virani SS; Am J Cardiol; 2015 Aug; 116(4):547-53. PubMed ID: 26089010 [TBL] [Abstract][Full Text] [Related]
20. Management of low-density lipoprotein cholesterol levels in South Africa: the International ChoLesterol management Practice Study (ICLPS). Blom DJ; Raal F; Amod A; Naidoo P; Lai YE; Cardiovasc J Afr; 2019 Jan/Feb 23; 30(1):15-23. PubMed ID: 30720848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]